Friday - July 17, 2026
UTSW, InterAct partner on novel gene therapy for metastatic cancer
March 24, 2026
DALLAS, Texas, March 24 -- The University of Texas Southwestern Medical Center posted the following news release:

* * *

UTSW, InterAct partner on novel gene therapy for metastatic cancer

UT Southwestern Medical Center and InterAct Therapeutics have announced an exclusive licensing agreement to develop and commercialize a groundbreaking computational platform and gene therapy pipeline targeting cancer metastasis.

The partnership centers on Inte . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products